The growing interest in cannabidiol (CBD), specifically a pure form of CBD, as a treatment
for epilepsy, among other conditions, is reflected in recent changes in legislation in some …

Cannabidiol (CBD) is a major active component of the Cannabis plant, which, unlike
tetrahydrocannabinol (THC), is devoid of euphoria-inducing properties. During the last 10 …

Psychotic disorders such as schizophrenia are heterogeneous and often debilitating
conditions that contribute substantially to the global burden of disease. The introduction of …

Cannabis can synthetize more than 400 compounds, including terpenes, flavonoids, and
more than 100 phytocannabinoids. The main phytocannabinoids are Δ-9 …

Cannabidiol (CBD) exhibits significant efficacy in mental and inflammatory diseases.
Several studies have recently reported on the rapid antidepressant-like effects of CBD …

The endocannabinoid system (ECS) is a widespread cell signaling network that maintains
homeostasis in response to endogenous and exogenous stressors. This has made the ECS …

Neurological dysfunctions are the most impactful and persistent consequences of traumatic
brain injury (TBI). Indeed, previous reports suggest that an association between TBI and …

The use of medical cannabis in children is rapidly growing. While robust evidence currently
exists only for pure cannabidiol (CBD) to treat specific types of refractory epilepsy, in most …

The signaling pathways associated with lipid metabolism contribute to the pathophysiology
of autism spectrum disorder (ASD) and provide insights for devising new therapeutic …

Purpose Therapeutic use of cannabidiol (CBD) in intractable epilepsies has increased
considerably over the last ten years. As more evidence for the potentially beneficial effects of …